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Introduction: Previous studies of microtia epidemiology globally have demonstrated
significant geographical and ethnic variation, cited broadly as affecting 3–5 in 10,000
live births. The aim of this study was to determine the incidence of microtia in a
largely homogeneous ethnic population in the United Kingdom (Wales) and to identify
factors, such as distance and socioeconomic status, which may influence the access to
surgical intervention.
Materials and Methods: A retrospective cohort study was conducted using data
linkage to identify patients born between 2000 and 2018 with a diagnosis of microtia.
Microtia incidence was calculated using annual and geographic birth rates. Surgical
operation codes were used to classify patients into those that had no surgery,
autologous reconstruction or prosthetic reconstruction. Sociodemographic attributes
were compared using descriptive statistics to determine differences in access to each
type of surgical intervention.
Results: A total of 101 patients were identified, 64.4% were male and the median age
was 12 (8–16). The mean annual incidence was 2.13 microtia cases per 10,000 births
over the 19-year study period. Both temporal and geographic variation was noted. The
majority of patients undergoing surgery opted for autologous reconstruction (72.9%) at
a median age of 9 (7–10) compared to 7 (5–8) for prosthetic reconstruction. Autologous
reconstruction had a higher median number of surgeries (2, 1–3) than prosthetic (1.5,
1–2) and a higher median socioeconomic status of 3 (2–4) compared to 2 (1–4) for
the prosthetic cohort. There were no statistically significant differences in the distance
traveled for surgery.
Discussion: This study highlights a role for data linkage in epidemiological analyses and
provides a revised incidence of microtia in Wales. Although the majority of patients opted
for autologous reconstruction, demographic disparities in socioeconomic status warrant
further investigation, emphasizing the importance of striving for equity in accessibility to
surgical intervention.
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INTRODUCTION
Abnormalities of the ear have been evident as early as the
prehistoric era (1), with the earliest documented records
of surgery from the Edwin Smith Surgical Papyrus and
Sushruta Samhita describing methods of reconstructing the
traumatized auricle (2, 3). Contemporary ear reconstruction
practices have evolved to encompass the spectrum of congenital
defects known as microtia, the presence of a smaller and
usually malformed auricle, or anotia in which the auricle is
absent in its entirety. Schiemeden first described auricular
reconstruction using costochondral grafts in 1908 (4), with
incremental refinements over the past century by individuals
such as Tanzer, Brent, Nagata, and Firmin (5–8). The latter two
approaches now dominate autologous reconstructive practice
worldwide (9). Alternatives to autologous reconstruction include
the use of prosthetics, which have emerged from the advent of
osseointegrated prosthesis retention by Branemark in 1977 (10)
and synthetic materials such as Medpor described by Reinisch in
1991 (11).
Microtia can present as an isolated phenotype or as
a manifestation of genetic syndromes such as Hemifacial
Microsomia, Treacher Collins or Goldenhar Syndrome. In
addition to its aesthetic impact, it can also affection function via
meatal atresia and hearing loss (12, 13). Microtia can therefore
be associated with significant functional and psychosocial issues,
such as impaired speech and language development (14),
attention deficit disorders (15), and psychological implications
for both the patient (16) and their careers (17).
An appreciation of the epidemiology of microtia is important,
owing to the high surgical burden and follow-up costs. In an
ideal healthcare system, service provision would mirror the
geographical distribution and clinical need of affected patients.
Previous studies of microtia prevalence globally have
demonstrated significant geographical and ethnic variation (18).
Although cited broadly as affecting ∼3–5 in 10,000 live births
(19), higher frequencies have been noted in certain ethnic groups
such as the Navajo population (12 per 10,000 births) (20) and
8.8 per 10,000 births in Chile (21). Studies have indicated a
male predisposition of up to 40% higher risk, and a primarily
unilateral phenotype in which the right ear is affected more
frequently than the left (12, 22). In Wales the prevalence of
microtia was previously reported as 1.11 per 10,000 births (18),
which is slightly higher than the average rate for Western Europe
(0.88 per 10,000 births).
In the United Kingdom (UK), surgical options for microtia
patients include both alloplastic and autologous reconstruction,
with the choice determined through discussions between the
patient, parents and clinicians from birth until 8 to 10 years of
age (9, 23). At this age, the auricle is ∼90% of its adult size
and childrenwill generally have acquired sufficient self-awareness
and psychosocial experience to contribute to the decision-
making process (24, 25). The rib cage is also developed to a
suitable size to support carving of the auricular framework. Both
autologous and alloplastic reconstruction have been previously
demonstrated to enhance quality of life of patients with microtia
and anotia (26) and in expert hands, offer excellent results with
relatively low complication rates (23). In the UK, plastic surgery
is a tertiary service, with auricular reconstruction offered at a
handful of specialist centers. Accessibility to, and awareness of,
these procedures may well be influenced by geographic and
social factors.
The aim of this study was to use data linkage to identify
a cohort of microtia patients in Wales and determine
geographical and socioeconomic variations in microtia
epidemiology and any association with the choice of autologous
or prosthetic reconstruction.
MATERIALS AND METHODS
The retrospective cohort study was designed and reported
in accordance with the Reporting of studies Conducted
using Observational Routinely-collected health Data (RECORD)
statement (27) and the STROBE statement (28).
Overview
Analysis of routine population-scale data from primary and
secondary care National Health Service (NHS) and national
administrative data sources for 2000–2018 in Wales, UK
(population 3.1 million) were performed. In instances where
relevant data were unavailable from a single source, multiple
data sources were linked. Data was retrieved from six national
data sources (Table 1). In Wales, population level de-identified
person-based health and socio-economic administrative data are
collated and linked within the Secure Anonymized Information
Linkage (SAIL) Databank (29–31). Robust policies, structures,
and controls are in place to protect privacy through a reliable
matching and anonymization process, achieved in conjunction
with the NHS Wales Informatics Service (NWIS) using a split
file multiple encryption approach described in detail in previous
published work (30).
Study Population
Microtia patients were identified from two separate sources, the
Welsh Longitudinal General Practice (WLGP) data using READ
codes for microtia (P422. Microtia; P401z Absence of external
ear NOS) and secondary care obtained from Patient Episode
Database for Wales (PEDW) and Outpatient Dataset for Wales
(OPDW) using the International Classification of Disease 10
(ICD-10) code Q17.2 Microtia.
Demographic information and socioeconomic status were
retrieved. The Welsh Index of Multiple Deprivation (WIMD)
version 2011, is used as the official area level measure of
socioeconomic status by the Welsh Government (48). Individual
scores are based upon a person’s postal address. Wales is
divided into 1,896 Lower layer Super Output Areas (LSOAs)
following the 2001 Census, each consisting of ∼1,600 people.
The WIMD scores for each LSOA are calculated and weighted
using data from eight domains of socioeconomic status (income,
employment, health, education, access to services, community
safety, physical environment, and housing socioeconomic
status). Each LSOA in Wales has been ranked according to
its WIMD score and grouped into quintiles, with quintile 5
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TABLE 1 | List of databases used for data linkage and their descriptions.
Database Description
Annual District Death Extract (ADDE) Collected from the Office for National Statistics (ONS), this database contains death registration
information, relating to Welsh Residents including those who died outside of Wales.
Outpatient Dataset for Wales (OPDW) Administrative and clinical data obtained from outpatient appointments in Wales.
Patient Episode Database for Wales (PEDW) Administrative and clinical data for all hospital admissions, including diagnosis and operations performed.
Welsh Cancer Intelligence and Surveillance Unit (WCISU) The national cancer registry for Wales. Captures all welsh melanoma patients from a number of sources;
Multi-Disciplinary Team data, pathology data, other routine data sources in Wales and the English cancer
registry.
Welsh Longitudinal General Practice dataset (WLGP) Administrative and clinical data from all patient visits to a General Practitioner.
Welsh Demographic Service (WDS) Administrative data about individuals resident or registered in Wales that have used National Health
Service (NHS) services.




Incidence rates were calculated for each year of the study and
per geographical local authority, using the number of live births
recorded for Wales from the Office of National Statistics as the
denominator and presented as a rate per 10,000 live births.
Operative Procedures
Patient Episode Database for Wales (PEDW) was used to
identify all day case and hospital admissions with inpatient
surgical procedures recorded. Patients were classified as
receiving no auricular reconstructive surgery, prosthetic
reconstructive surgery or autologous reconstructive surgery
based on appropriate Office of Population Censuses and Surveys
Classification of Interventions and Procedures (OPCS-4) codes.
Access to Healthcare
For each individual surgical procedure, Geographic Information
System (GIS) software was used to calculate the geodesic
distances (i.e., straight-line distance) between each patient’s
LSOA to the respective treatment center. To ensure data
anonymity, patient addresses are not stored in SAIL. Centroid
co-ordinates of each patient’s LSOA were used as a proxy for
their location.
Ethical Approval
Approval for the use of anonymized data in this study,
provisioned within the Secure Anonymized Information Linkage
(SAIL) Databank was granted by an independent Information
Governance Review Panel (IGRP) under project 0651. The IGRP
has a membership comprised of senior representatives from
the British Medical Association (BMA), the National Research
Ethics Service (NRES), and Public Health Wales and NHS
Wales Informatics Service (NWIS). Usage of additional data was
granted by data owner. The SAIL Databank is General Data
Protection Regulations (GDPR) and the UK Data Protection
Act compliant.
The data sources used in this study are available in the
SAIL Databank at Swansea University, Swansea, UK, but as
restrictions apply they are not publicly available. All proposals
to use SAIL data are subject to review by an independent
Information Governance Review Panel (IGRP). Before any data
can be accessed, approval must be given by the IGRP. The IGRP
gives careful consideration to each project to ensure proper and
appropriate use of SAIL data. When access has been granted, it is
gained through a privacy protecting safe haven and remote access
system referred to as the SAIL Gateway. SAIL has established
an application process to be followed by anyone who would
like to access data via SAIL at https://www.saildatabank.com/
application-process.
Statistical Analysis
Descriptive statistics (median and interquartile range) were used
to characterize the microtia cases and a chi squared test was
used to determine disparities between the cohorts that underwent
surgical intervention. All data were analyzed using IBM SPSS
Statistics for Windows (IBM Corp. Released 2017. Version 25.0.
Armonk, NY: IBM Corp). Statistical significance was assumed
with a p < 0.05.
RESULTS
Demographics
Between 2000 and 2018, 101 patients in Wales were born with
a diagnosis of microtia. The demographic data of this cohort is
outlined in Table 2. 65 (64.4%) were recorded as being of male
sex at birth.
There were no statistically significant differences in the
proportion of patients within each WIMD quintile (p = 0.85)
with a median deprivation (WIMD) score of 3 [Inter Quartile
Range (IQR) 2–4]. Of the patients in this cohort, <5 (4%) had
microtia as part of a congenital syndrome.
Microtia Incidence and Geographic
Distribution
The incidence of microtia in Wales between 2000 and 2018
was 2.13 cases per 10,000 births. Annual birth rate data
per local authority area was only available from the Welsh
Government between the years of 2000 and 2015 and was
used to determine the geographical incidence of microtia in
Wales during this time period. There was noted to be variability
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TABLE 2 | Patient Demographics assessed at the time of analysis (April 2020).
Parameter Total (n = 101) No Operation (n = 53) Prosthetic (n = 13) Autologous (n = 35) P-value
Age at time of analysis (years), n (%)
<5 9 (9) 9 (17) 0 (0.0) 0 (0) 0.00
5–10 31 (31) 26 (49) <5 (25) <5 (<6)
11–15 29 (29) 8 (15) 8 (62) 13 (37)
16–20 28 (28) 8 (15) <5 (25) 18 (51)
>20 <5 (<5) <5 (<5) 0 (0) <5 (<6)
Median age (IQR) 12 (8–16) 8 (6–12) 11.5 (10–13) 15 (13–16.5)
Sex, n (%)
Male 65 (64) 36 (68) 8 (62) 21 (60) 0.73
Female 36 (36) 17 (32) 5 (39) 14 (40)
WIMD Quintile, n (%)
1 (lowest socioeconomic status) 21 (21) 9 (17) 5 (42) 7 (20) 0.61
2 23 (23) 13 (25) <5 (<20) 8 (23)
3 19 (19) 12 (23) <5 (<20) 5 (14)
4 20 (20) 9 (17) <5 (<20) 10 (29)
5 (highest socioeconomic status) 16 (16) 9 (17) <5 (<20) 5 (14)
Unspecified <5 (<5) <5 (2) <5 (<20) 0 (0)
Median (IQR) 3 (2–4) 3 (2–4) 2 (1–4) 3 (2–4)
Number of Procedures, n (%)
0 51 (51) 51 (96) – – 0.00*
1 24 (24) <5 (<5.0) 7 (54) 15 (43)
2 14 (14) – <5 (<35) 10 (29)
3 8 (8) – <5 (<35) 7 (20)
4 <5 (<5) – 0 (0) <5 (9)
5 0 (0) – 0 (0) 0 (0)
6 <5 (<5) – <5 (<35) 0 (0)
Median number of procedures Median (IQR) 1 (0–2) 0 (0) 1.5 (1–2) 2 (1–3)
*p = 0.29 between prosthetic and autologous cohorts
Median age of surgical Intervention (years)
Median (IQR) 8 (5–10) – 7 (5–8) 9 (7–10) 0.02
Distance Traveled for Surgery (miles), n (%)
<20 23 (48) – 5 (39) 18 (51) 0.37
20–50 12 (25) – <5 (<35) 8 (23)
50–100 7 (15) – <5 (<35) 6 (17)
>100 5 (10) – <5 (<35) <5 (<10)
Unspecified <5 (<5) – <5 (<35) 0 (0)
Median (IQR) 20.8 (6.9–51.5) – 32.2 (7.9–50.4) 19.9 (6.9–51.5)
in the incidence of microtia throughout the different local
authorities of Wales (Figure 1), with the highest incidences per
10,000 live births noted in Monmouthshire (5.54) followed by
Bridgend (5.18).
Conversely, there were no reported cases of microtia in
Ceredigion or Blaenau Gwent during this study period, and the
lowest incidences per 10,000 live births were noted in Caerphilly
(0.86) and Flintshire (1.07).
Annual birth data for Wales as a nation was available from
2000 to 2018. During this period, there was an annual fluctuation
in the incidence of microtia cases per 10,000 live births. A peak
annual incidence of 2.96 was noted in 2013, with the lowest
incidence of 0.3 in 2015 (Figure 2).
Surgical Intervention: Autologous and
Prosthetic Reconstruction
Of the 101 microtia patients in this cohort, 48 patients (47.5%)
had auricular reconstructive surgery during the study period
(2000–2018). Of the 48 patients who had reconstructive surgery,
13 (27.1%) had a record of receiving a prosthetic auricular
replacement and 35 patients (72.9%) were noted to have
undergone an autologous auricular reconstruction. There were
no significant differences in sex or deprivation scores between the
patients in the non-operative, prosthetic and autologous groups.
With regard to patients undergoing reconstructive surgery, the
median age of surgical intervention was higher in the autologous
reconstruction cohort at 9-years of age, compared to 7-years
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FIGURE 1 | Heat map to demonstrate the regional variability in microtia incidence per 10,000 live births in Wales between 2000 and 2015.
FIGURE 2 | Annual incidence of microtia in Wales during study period 2000–2018.
of age in the prosthetic cohort (p = 0.02). WIMD score was
higher (indicating less deprived) in the autologous cohort (3,
IQR = 2–4) compared to the prosthetic group (more deprived;
medianWIMD score 2, IQR= 1–4) but this was not a statistically
significant difference (p= 0.488).
Of the 101 patients, 53 patients had no recorded surgical
intervention recorded during the study period (2000–2018).
Sixty-six percent of these patients were in the younger age
categories (<10 years of age), and a younger median age
was seen in this cohort (8, IQR = 6–12) compared to
the patients in the autologous (15, IQR = 13–16.5) and
prosthetic (11.5, IQR = 10–13) reconstruction cohorts (p <
0.00). Fewer than 5% in the “No operation” cohort underwent
procedures to the auricle, of which neither were reconstructive in
nature (Table 2).
The median number of surgeries in the prosthetic group
was 1.5 (IQR = 1–2) and in the autologous group was 2 (IQR
= 1–3). No statistical difference was observed between the
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number of procedures between the prosthetic and autologous
groups (p= 0.29).
Geodesic Distance Traveled for Surgery
Themedian geodesic distance traveled for all patients undergoing
surgical intervention was 20.81 miles (IQR = 6.9–51.5). In the
autologous reconstruction cohort, a median distance of 19.86
miles was traveled for surgical intervention (IQR = 6.9–51.5
miles) and in the prosthetic group a larger median distance of
32.22 miles was traveled (IQR= 7.9–50.4). The majority (47.9%)
of patients were within a 20miles radius from their site of surgery
(Figure 3). The differences in distance traveled by each cohort
were not statistically significant (p= 0.37).
Out of the 48 patients who had surgical intervention, 10
(20.8%) had procedures undertaken in England with a median
geodesic distance of 104.2 miles to the site of surgery, of which 6
(60%) of these cases were autologous reconstructions. There were
no cases known to be performed outside of the United Kingdom.
Of the 38 cases (79.2%) performed in Wales, 31 cases were done
in The Welsh Center for Burns and Plastic Surgery, Morriston
Hospital, Swansea, and 7 in other Welsh hospitals.
There was noted to be geographical variation in the median
distance traveled for surgery throughout Wales (Figure 4).
Patients located in the peripheries of the country such as Powys
(83.0 miles), Newport (125.2 miles), Anglesey (83.3 miles),
and Flintshire (91.4 miles) were amongst the highest median
geodesic distances traveled. There was no statistically significant
association between WIMD quintile and distance traveled (p
= 0.07).
DISCUSSION
This study is the first to our knowledge to detail the regional
epidemiology of microtia in a large homogenous population
in the United Kingdom (3.1 million) including the association
between incidence, socioeconomic deprivation, and access to
reconstructive surgery.
FIGURE 3 | Geodesic distances traveled by patients undergoing microtia reconstructive surgery in Wales.
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FIGURE 4 | Heat map to demonstrate the regional variability in geodesic distance traveled for surgery in Wales.
Previously published epidemiological data derived from the
International Clearinghouse for Birth Defects Surveillance and
Research database calculated the incidence of microtia in Wales
to be 1.11 per 10,000 births between 1998 and 2007 (18).
Our study provides a revised incidence statistic of 2.13 per
10,000 births based on a broader, more recent period of 19
years (2000–2018). The more accurate detection rate of more
than double the number microtia diagnoses in this study is via
the use of data linkage to enable the retrieval of information
from a combination of secondary care inpatient and outpatient
data, in addition to primary care GP records. Although the
overall incidence is comparable to epidemiological studies of
predominantly Caucasian populations in California, US (2.2
per 10,000 births) and Sweden (2.4 per 10,000 births), it is
significantly higher than the published rates for England (0–
0.7 per 10,000 births) and quoted Western European rates as a
whole (0.88 per 10,000 births) (18, 32, 33). The sex ratio in our
cohort (64% Male: 36% Female) is in line with contemporary
European data from Finnish (34) and German studies (35), in
addition to heterogenous ethnic populations in Japan (15), USA
(36), Venezuela (37), and Mexico (38).
The incidence of microtia in Wales displayed geographic
variability, with a difference in incidence >4-fold observed
between local authorities. The highest incidences of microtia
was in South-Eastern areas of Wales such as Bridgend and
Monmouthshire (>4 per 10,000 births), with relatively low
incidences in Western areas of Wales such as Ceredigion,
Pembrokeshire, and Carmarthenshire. This variability could be
related to a number of factors, including engagement with
medical services in rural communities, a reflection of the low
numbers of cases or the limitations of incomplete capture or
misclassification of diagnoses and procedures that can occur.
Nonetheless, geographic variability of microtia incidence has
been previously shown in studies of the USA, Germany,
Australia, England, and France (18).
Although our study population has a homogeneous ethnic
population [94.1% Caucasian (47)], there is a wide spectrum
of socioeconomic deprivation, offering useful insight for
epidemiological analyses. In this study, the incidence of
microtia appeared to be largely uniform in distribution between
WIMD quintiles, with no statistically significant association
observed between incidence and deprivation. This contrasts with
previously published associations between microtia incidence
and maternal educational status (33, 39) and socioeconomic
deprivation in Hispanic populations (40). To date, there are
a very limited number of studies in which the association
between microtia incidence and socioeconomic deprivation has
been explored in European populations, and there are none
to date from the UK. An Italian cohort study determined no
significant association between maternal education (as a marker
of deprivation) and microtia incidence (41). In the UK, studies
have demonstrated no association between socioeconomic
deprivation and craniofacial syndromes (42) but an association
between deprivation and congenital deafness (42) and in Wales
specifically, the incidence of orofacial clefts (43).
This study indicates that the observed regional variability in
microtia incidence in Wales is independent of the influence of
socioeconomic deprivation and given the homogeneity of the
population is unlikely to be related to ethnicity.
An additional aim of this study was to calculate the proportion
of patients who opt for autologous vs. prosthetic reconstruction
and to determine whether any demographic differences or
inequalities exist in these cohorts. Of the patients who had not
been operated on to date, just over 65% were still too young to be
surgical candidates, which has limitations for drawing definitive
conclusions relating to reconstructive modality.
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Of the 48 patients who had surgery, the majority (73%) opted
for autologous reconstruction. The median age of autologous
ear reconstruction surgery was nine in our study, in line with
UK guidelines (9, 23, 25), and the accepted wisdom that the ear
is ∼90% of its adult size by 8–10 years of age. This correlates
with the age range in which children develop the self-awareness
and psychosocial experiences to contribute to surgical decision
making and when the rib cage is developed enough to allow
harvest and carving with relative ease. The median age of
alloplastic ear reconstruction was 7, which reflects both the
younger age that these procedures can be performed, and the time
needed to make a definitive reconstructive decision.
The patients opting for prosthetic reconstruction were from
more deprived populations than the autologous group, with
41.7% of patients in the prosthetic cohort being in the most
deprived WIMD quintile. Although not statistically significant,
this is a clinically significant finding which warrants reflection.
Autologous reconstruction is a complex surgical concept, and
certainly in this study, is associated with a higher number of
surgical procedures than alloplastic reconstruction. It is our duty
as service providers to ensure that the information we provide
to patients regarding surgical options is tailored, comprehensive
and accessible to patients of all backgrounds and that inequalities
in access to surgery are acknowledged, addressed and where
possible, surmounted. Our previous work has shown that patient
information sheets may not tailor to the average UK reader (44),
with 1 in 6 individuals in the UK believed to have a literacy level
below that expected of an 11 year old (46), and as a result of this,
we are currently working on a bespoke patient information sheet
for Microtia to accommodate the variation in literacy skills.
Our data demonstrates that the most deprived populations
appeared to correlate with the lowest distances traveled for
surgery. There are limitations in using the geodesic distance
as a measure of travel, as it may markedly underestimate the
distance patients endure as dictated by road and railway routes.
It does, however, enable crude comparisons of the spectrum
of distances traveled by patients from different geographical
areas. Further work could be completed in the future to
utilize network analyses utilizing road and travel data sources
to evaluate more accurate distance and time point to point
results, but this would have required additional permissions to
access anonymized residential location identifiers for the cohort.
The trend was toward the most deprived populations traveling
the shortest distances, with the most deprived populations in
WIMD quintiles 1 and 2 comprising 60.5% of those traveling
<20 miles but only comprising 28.6% of patients traveling
over 100 miles. Although there are no significant differences
in the distance traveled for surgery between autologous and
prosthetic groups, 60% of the patients who traveled to England
were for autologous surgery with a median distance of >100
miles, despite this service being offered in Swansea. This
reinforces the need for a robust and unified referral and
treatment pathway for ear reconstruction in Wales, to address
some of the inequalities in access to surgery and minimize
the risk that ease of accessibility to one type of surgery may
influence patient choice. This emphasizes the importance of
a multidisciplinary team approach to enable information to
be disseminated between clinicians treating microtia patients
in Wales, which as per UK Care Standards should include a
minimum of a reconstructive surgeon, otologist, audiologist,
pediatrician with audiology interests, a clinical psychologist,
specialist nurse, and anaplastologist (45).
CONCLUSION
This study applied data-linkage methods to determine the 19-
year incidence of microtia in a homogenous UK population (3.1
Million) to be greater than double previously reported values
and highlighting that both temporal and geographical variation
in microtia incidence exists. The majority of patients in this
cohort opted for autologous reconstructive surgery, with the
possibility that socioeconomic deprivation may bear an influence
on the choice of reconstructive modality, which warrants further
investigation, particularly where patients are required to travel
long distances to access surgical intervention.
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